Search Results 71-80 of 16658 for primary sclerosing cholangitis
Mayo Clinic researchers were among the first to describe primary sclerosing cholangitis. Other research done at Mayo has helped to refine diagnostic tests, ...
The purpose of this study is to evaluate the effectiveness and safety of obeticholic acid in patients with primary sclerosing cholangitis, evaluating its ...
... Primary Sclerosing Cholangitis (PSC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
ROCHESTER, Minn. — Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, ...
Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation · Overview · Participation ...
Primary sclerosing cholangitis affects 1 in 10,000 individuals, with about 75 percent developing inflammatory bowel disease (IBD), most often in the form of ...
Most people with primary sclerosing cholangitis also have some type of inflammatory bowel disease, such as ulcerative colitis or Crohn's disease, often leading ...
... primary sclerosing cholangitis in the present can look forward to a brighter future. It's both a mouthful and a ruthless condition: primary sclerosing ...
Primary Biliary Cirrhosis (PBC) is a serious, life--threatening, bile acid related liver disease of unknown cause. Without treatment, it frequently progresses ...
The purpose of this study is to evaluate the safety and effectiveness of curcumin used in patients with primary sclerosing cholangitis. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.